Immediate Impact
61 standout
Citing Papers
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
2024 Standout
Works of Bo Wei being referenced
Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric Cancer
2017
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Bo Wei | 125 | 57 | 68 | 111 | 69 | 30 | 297 | |
| Kai Huang | 109 | 95 | 66 | 54 | 83 | 33 | 328 | |
| Yong Li | 145 | 33 | 114 | 46 | 38 | 29 | 279 | |
| Yuhui Liu | 136 | 50 | 99 | 181 | 32 | 27 | 309 | |
| Wenqi Xi | 143 | 81 | 177 | 48 | 77 | 33 | 332 | |
| Yasuhisa Fujimoto | 39 | 38 | 72 | 73 | 65 | 36 | 248 | |
| Jiamei Chen | 80 | 87 | 102 | 49 | 68 | 24 | 304 | |
| Letizia Laera | 173 | 99 | 117 | 51 | 72 | 32 | 317 | |
| J.L. Carreras-Delgado | 85 | 40 | 73 | 142 | 41 | 28 | 310 | |
| Burçak Yılmaz | 161 | 38 | 91 | 94 | 23 | 29 | 286 | |
| Yusuke Onozato | 68 | 60 | 35 | 104 | 28 | 29 | 277 |
All Works
Login with ORCID to disown or claim papers
Loading papers...